Systemic treatment of severe atopic eczema: a systematic review - PubMed
Review
Systemic treatment of severe atopic eczema: a systematic review
Jochen Schmitt et al. Acta Derm Venereol. 2007.
Free article
Abstract
Systemic immunosuppressive agents are recommended for patients with atopic eczema in whom disease activity cannot be controlled adequately with topical treatments. Guidelines do not give clear advice which agents to prefer. We systematically reviewed clinical trials on systemic treatment for severe atopic eczema to provide evidence-based treatment recommendations. Standardized literature search, independent standardized assessment of eligibility and data abstraction was performed by 2 reviewers. Twenty-seven studies totalling 979 patients were included. Eleven studies consistently showed effectiveness of cyclosporine. Cyclosporine is recommended as first option for patients with atopic eczema refractory to conventional treatment. Evidence from randomized controlled trials also exists for interferon-? and azathioprine. Although frequently used in clinical practice, systemic glucocorticosteroids have not been assessed adequately in studies. Mycophenolate mofetile showed effectiveness in 2 small uncontrolled studies. Intravenous immunoglobulins and infliximab are not recommended based on published data.
Similar articles
-
Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. Roekevisch E, et al. J Allergy Clin Immunol. 2014 Feb;133(2):429-38. doi: 10.1016/j.jaci.2013.07.049. Epub 2013 Oct 24. J Allergy Clin Immunol. 2014. PMID: 24269258 Review.
-
Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis.
Schmitt J, Schmitt N, Meurer M. Schmitt J, et al. J Eur Acad Dermatol Venereol. 2007 May;21(5):606-19. doi: 10.1111/j.1468-3083.2006.02023.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17447974 Review.
-
Update on systemic therapies for atopic dermatitis.
Denby KS, Beck LA. Denby KS, et al. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):421-6. doi: 10.1097/ACI.0b013e3283551da5. Curr Opin Allergy Clin Immunol. 2012. PMID: 22622476 Review.
-
Novel immunological approaches in the treatment of atopic eczema.
Belloni B, Andres C, Ollert M, Ring J, Mempel M. Belloni B, et al. Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):423-7. doi: 10.1097/ACI.0b013e32830fb8fd. Curr Opin Allergy Clin Immunol. 2008. PMID: 18769195 Review.
-
Atopic dermatitis: systemic immunosuppressive therapy.
Akhavan A, Rudikoff D. Akhavan A, et al. Semin Cutan Med Surg. 2008 Jun;27(2):151-5. doi: 10.1016/j.sder.2008.04.004. Semin Cutan Med Surg. 2008. PMID: 18620137 Review.
Cited by
-
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.
Arehart CH, Daya M, Campbell M, Boorgula MP, Rafaels N, Chavan S, David G, Hanifin J, Slifka MK, Gallo RL, Hata T, Schneider LC, Paller AS, Ong PY, Spergel JM, Guttman-Yassky E, Leung DYM, Beck LA, Gignoux CR, Mathias RA, Barnes KC. Arehart CH, et al. J Allergy Clin Immunol. 2022 Jan;149(1):145-155. doi: 10.1016/j.jaci.2021.05.034. Epub 2021 Jun 7. J Allergy Clin Immunol. 2022. PMID: 34111454 Free PMC article.
-
[Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit].
Schmitt J, Schäkel K. Schmitt J, et al. Hautarzt. 2007 Feb;58(2):128, 130-2. doi: 10.1007/s00105-006-1280-y. Hautarzt. 2007. PMID: 17237929 German.
-
Oranje AP. Oranje AP. Indian J Dermatol. 2014 Mar;59(2):140-2. doi: 10.4103/0019-5154.127673. Indian J Dermatol. 2014. PMID: 24700931 Free PMC article.
-
Oral evening primrose oil and borage oil for eczema.
Bamford JT, Ray S, Musekiwa A, van Gool C, Humphreys R, Ernst E. Bamford JT, et al. Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD004416. doi: 10.1002/14651858.CD004416.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633319 Free PMC article. Review.
-
Systemic treatment of adult atopic dermatitis.
Cookson H, Smith C. Cookson H, et al. Clin Med (Lond). 2012 Apr;12(2):172-6. doi: 10.7861/clinmedicine.12-2-172. Clin Med (Lond). 2012. PMID: 22586797 Free PMC article. Review. No abstract available.